Anemia Management: Paradigm Shift or Hype?

8 Feb 2025 9:45 a.m. 11:15 a.m.

Amaltas Hall B101-B

DineshKhullar Chair India

Fatiu AbiolaArogundade Chair NigeriaObafemi Awolowo University Teaching Hospitals Complex/ National Postgraduate Medical College of Nigeria

MayuriTrivedi Chair IndiaSenior consultant and Head Department of Nephrology LTMG hospital,Mumbai,India

Session Description:
Anaemia is a common complication of kidney disease. Are the newer therapies any better than the old ones? In this session we will look at guideline-based therapy for anaemia and critically appraise the role of iron in its management.
Learning Objectives:
Discuss the guideline-based treatment of anaemia, Analyse the role of HIF-PHIS in the current management of anaemia. Review the role of iron and discuss consequences of iron overload.

Time	Session

9:45 a.m. 10:03 a.m.	Guideline-based Treatment of Anaemia of CKD: What's New? LF03-01 Kai-UweEckardt Speaker GermanyDepartment of Nephrology and Medical Intensive Car
10:03 a.m. 10:21 a.m.	HIF-PHIs: Two Sides of the Same Coin LF03-02 Chuan-MingHao Speaker ChinaFudan University Huashan Hospital
10:21 a.m. 10:39 a.m.	Iron Therapy in CKD: Moving Targets LF03-03 EviNagler Speaker BelgiumNephrology Department, Ghent University Hospital,
10:39 a.m. 10:57 a.m.	Consequences of Iron Overload LF03-04 RobertKalyesubula Speaker UgandaMakerere, University
10:57 a.m. 11:15 a.m.	Q&A LF03-05